BIONEUTRAL

BIO Debt-to-Equity Ratio Analysis

0.17x

Higher than 48% of Healthcare sector peers

Updated 413h ago·SEC filings & market data

Key Takeaway

The debt-to-equity ratio divides total liabilities by shareholder equity, showing how much debt a company uses to fund its assets relative to owner capital.

Sector Performance

48th percentile

BIO

0.17x

Sector Median

0.26x

Sector Avg

0.89x

Prior Period

0.18x(Jul 2026)

↑ Improving
📊

Deep Analysis

The debt-to-equity ratio divides total liabilities by shareholder equity, showing how much debt a company uses to fund its assets relative to owner capital.

A 0.17x current value means Bio-Rad holds $0.17 of debt for every $1 of equity, indicating low financial leverage. This is below the healthcare sector median of 0.45x, placing the company at the 44th percentile among peers, so it carries less debt than most but not the least. The year-over-year change is N/A, while the quarter-over-quarter change is -5.6%, reflecting a decline from 0.18x to 0.17x in the most recent period. A low and falling ratio suggests the company is reducing debt or increasing equity, which lowers financial risk and can be seen as a defensive quality. That combination supports a neutral view: leverage is conservative, but the moderate percentile shows no standout advantage. The metric therefore directly supports the overall NEUTRAL verdict rather than contradicting it.

Frequently Asked Questions

What does the Debt-to-Equity Ratio tell investors about BIO?

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

How is the Debt-to-Equity Ratio calculated?

Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.

How does BIO's Debt-to-Equity Ratio compare to its sector?

BIO's Debt-to-Equity Ratio of 0.17x compares to a Healthcare sector median of 0.26x, placing it in the 48th percentile.

Who are BIO's closest peers by Debt-to-Equity Ratio?

The closest Healthcare peers by Debt-to-Equity Ratio include: BIIB (0.34x), NTLA (0.13x), TECH (0.10x), BEAM (0.09x), RVTY (0.45x).

The Formula

Total Debt / Shareholders' Equity

Why It Matters

Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.

Advertisement

Master BIO's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BIO research report

Free account — no credit card

BIO

0.17x

Sector Median

0.26x

Sector Avg

0.89x

How BIO's Debt-to-Equity Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.